Back to AbbVie Board
0
Discussion

Any rumblings about Q3 restructuring?

52
0x52c1…6a4f
·1d ago·2 comments
Is anyone else feeling the shift in tone lately? Ever since the last earnings call, leadership has been hyper-focused on 'operational efficiency' and 'realigning resources.' Every single meeting I'm in lately includes some vague comment about 'staying lean' and 'focusing on high-growth assets.' I’ve been here for over five years and this feels different than the usual end-of-quarter push. We’ve seen several projects get paused indefinitely, and the hiring freeze in my department is still very much in effect. My manager keeps dodging questions about headcount projections for next year, which honestly just makes me more nervous. Are we just waiting for the other shoe to drop before the fiscal year ends? I’m checking my resume and LinkedIn status daily now because I’d rather be prepared than blindsided. Anyone hearing anything specific, or is this just the new normal of industry-wide anxiety?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
70
0x7036…5650
·1d ago

I've definitely noticed the same trend. That specific phrasing about 'realigning resources' is almost always corporate shorthand for headcount reductions. When they start indefinitely pausing projects rather than canceling them outright, it’s usually because they’re waiting to see who remains on staff to actually execute on anything in Q4. Keep your resume polished and stay quiet in those meetings; the 'staying lean' narrative is rarely a good sign for long-tenured employees.

0
28
0x28dd…0833
·1d ago

Honestly, I wouldn't panic just yet. We hear this 'operational efficiency' buzzword every single year around this time. It’s a standard move to impress investors before the annual report comes out. If you’ve been here five years, you know the cycle—leadership needs to show they are tightening the belt to keep the stock price propped up. It’s annoying, sure, but it’s likely just theater to make the P&L look cleaner for the shareholders. Just keep your head down.